ORGO (Organogenesis Holdings) EV-to-EBIT : -25.47 (As of May. 17, 2025)

Organogenesis Holdings EV-to-EBIT Chart

Organogenesis Holdings Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					33.13	17.17	16.75	43.92	-342.44

Organogenesis Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															31.93	-35.96	-30.79	-342.44	-34.40

Competitive Comparison of Organogenesis Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Organogenesis Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organogenesis Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organogenesis Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Organogenesis Holdings's EV-to-EBIT falls into.

Organogenesis Holdings EV-to-EBIT Calculation

Organogenesis Holdings's EV-to-EBIT for today is calculated as:

Organogenesis Holdings's current Enterprise Value is $448.5 Mil.
Organogenesis Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organogenesis Holdings  (NAS:ORGO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Organogenesis Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Organogenesis Holdings's Enterprise Value for the quarter that ended in Mar. 2025 was $605.8 Mil.
Organogenesis Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organogenesis Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Organogenesis Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Organogenesis Holdings Business Description